Page 12 - Morphosys This News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Morphosys this. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Morphosys This Today - Breaking & Trending Today

JPMorgan sees high potential in Morphosys

U.S. bank JPMorgan is giving antibody specialist Morphosys plenty of advance praise months before the crucial data readout on its cancer drug pelabresib. More likely than failure is that the trial. | June 16, 2023 ....

United States , James Gordon , Constellation Pharmaceuticals , Morphosys Ag Stock Exchange , Press Release , He Mor De0006632003 ,

MorphoSys AG (NASDAQ:MOR) Receives $9.97 Consensus Price Target from Analysts

Shares of MorphoSys AG (NASDAQ:MOR – Get Rating) have been given an average rating of “Hold” by the eight brokerages that are covering the firm, MarketBeat reports. Five research analysts have rated the stock with a sell rating, one has issued a hold rating and two have issued a buy rating on the company. The […] ....

Morphosys Company Profile , Optiver Holding , T Rowe Price Investment Management Inc , Opaleye Management Inc , Td Asset Management Inc , Get Rating , Capital Management , Management Inc , Price Investment Management , Morphosys Daily , Nasdaq Mor ,

MorphoSys To Release Myelofibrosis Trial Data This Year

Shares of MorphoSys AG (MOR), which have been experiencing strong momentum this year, touched a new 52-week high of $6.85 during intraday trading yesterday.. ....

United Kingdom , Lenalidomide Revlimid , Incyte Jakafi , Incyte Corp , Nasdaq Global Market , Blood Cancer , Bone Marrow ,